Vyleesi: The Review Of The Latest Female Viagra Approved By FDA

It’s called Vyleesi, it’s fresh from marketing in the USA and promises to cure libido decrease. We have been talking about female Viagra for years, the pharmaceutical industry does not give up, the search for perfect pink pill that can improve women’s sexual desire seems to be the new Holy Grail of pharmacology. They tried with the Addyi, the first equivalent of Viagra for women, and the results were not great. So many side effects, tepid sales and a progressive disappearance from the efficacy radars have not discouraged new studies to medically resolve the lowering of female libido. And, in the wake of the powerful sex scenes of Game Of Thrones, the name of the new female Viagra Vyleesi has arrived, a drug specifically designed for the treatment of low sexual drive and freshly approved for marketing by the Food And Drug Administration.

The new Viagra for women will not be in pills like the previous one, and the active ingredient is also different. Unlike the actual Female Viagra over the counter based on sildenafil citrate, Vyleesi is based on bremelanotide, can be taken safely even after a dinner and glasses of wine and is administered with a pen injector, similar to those used for insulin injections. And the principle is the same: a puncture (in the leg or abdomen) about 45 minutes before having sex (so there is plenty of time for a long foreplay). The manufacturer company AMAG has not yet made it known nether what the cost of the female Viagra will be, nor whether Vyleesi will be covered (even partially) by American health insurance, as it happens for drugs to treat erectile dysfunction.

Female Viagra

Furthermore, several conflicting opinions persist on the efficacy. There are all sorts of side effects in Vyleesi. Not like those that led to the failure of the Addyi, but neither were they minors. In clinical trials, 40% of women had strong sense of nausea, so much so that 18% of participants had to abandon the trial directly due to this unpleasant aspect. And there have also been cases, however rare, of skin darkening on the genitals and on the body that have not always disappeared after the end of the clinical test. The recommendation to not take drugs for sexual desire remains if you have cardiovascular diseases, which unites men and women.

The doubts about the efficacy of the new female Viagra remain, despite everything. The public reception of the news was lukewarm, despite the push of the pharmaceutical lobby, and the decision to treat certain complex conditions such as the decline in female desire (which is not as mechanical as those of male) with still unstable medicines does not seem to be highly appreciated by US sexologists.

The problem of the decline of female and male desire exists, this is not questioned. But what if hypothetical care cannot be solved only with drugs, but from better sex and greater awareness of what your body likes, discovering yourself and each other with various types of avant-garde sex toys, and stimuli that can come from anywhere? Isn’t it that in the anxiety of equating men and women the first true rule of feeling pleasure, or the knowledge of the body, is swept under the rug?

Published by Evelyn Green